Middle East & Africa Aesthetic Injectable Devices Market Size and Forecast (2021

Description

List of Tables

The Middle East and Africa (MEA) Aesthetic Injectable Devices Market is projected to grow significantly, with an expected market size of approximately US$ 630.2 million by 2031, up from US$ 393.3 million in 2024. This growth represents a compound annual growth rate (CAGR) of 7.1% from 2025 to 2031.

Executive Summary and Market Analysis

The MEA region, which includes countries such as the UAE, Saudi Arabia, and South Africa, is experiencing a notable expansion in the aesthetic injectable devices market. This surge in demand is primarily driven by increasing awareness and acceptance of cosmetic procedures across various demographics, including younger consumers and affluent individuals. Non-invasive treatments, particularly Botox and dermal fillers, are favored for their minimal recovery times and immediate visible results, contributing significantly to market growth.

Moreover, improvements in healthcare infrastructure and technology, along with a rise in medical tourism, are enhancing accessibility to these aesthetic procedures. The growing number of qualified dermatologists and cosmetic surgeons in the region is also facilitating this trend, making aesthetic treatments more available to a broader audience.

Strategic Insights

Market Segmentation Analysis

The MEA Aesthetic Injectable Devices Market can be segmented based on several criteria:

By Product: The market is divided into Dermal Fillers, Botulinum Toxin, and Others. In 2024, Botulinum Toxin held the largest market share.
By Dermal Fillers: This segment includes Calcium Hydroxylapatite, Hyaluronic Acid, Collagen, Poly-L-Lactic Acid, Polymethylmethacrylate (PMMA), Fat Fillers, and Others. Hyaluronic Acid was the leading product in this category in 2024.
By Device: The market is categorized into Microcannulas, Pre-Filled Syringes, Mesotherapy Guns, and Others, with Pre-Filled Syringes dominating the market share in 2024.
By Application: Applications include Facial Line Correction, Face Lift, Lip Treatment, Anti-Aging and Wrinkle Treatment, Acne and Scar Treatment, Stretch Marks, and Others. Facial Line Correction was the most significant application in 2024.
By Age Group: The market is segmented into Up to 30, 31-40, 41-50, 51-60, and More Than 60, with the 31-40 age group holding the largest share in 2024.
By Gender: The market is divided into Female and Male, with females representing the majority of the market share in 2024.
By End User: This includes Medical Spas, Dermatology Clinics, Hospitals, and Others, with Dermatology Clinics leading the market in 2024.

Market Outlook

The preference for aesthetic injectables over traditional surgical procedures is growing due to their lower risks, quicker recovery times, and effective results without the need for invasive surgery. Treatments such as Botox and hyaluronic acid fillers are effective in addressing skin concerns like wrinkles, fine lines, and loss of facial volume. The global trend towards non-surgical aesthetic procedures is on the rise, as many individuals prioritize their appearance as a key aspect of their overall well-being.

According to the International Society of Aesthetic Plastic Surgery (ISAPS), there were 19.1 million non-surgical procedures performed globally in 2023. The most popular among these were hyaluronic acid and botulinum toxin treatments, with botulinum toxin being the most performed non-surgical procedure across all demographics, totaling 8.8 million treatments in 2023. Hyaluronic acid procedures also saw a significant increase, with a total of 5.5 million procedures performed, marking a 29% rise.

The increasing popularity of non-surgical enhancements and the growing patient base are driving the demand for aesthetic injectable devices, thereby propelling market growth.

Country Insights

The MEA Aesthetic Injectable Devices Market is further segmented by country, including Saudi Arabia, South Africa, the UAE, and the Rest of the MEA. South Africa held the largest market share in 2024. According to ISAPS, South Africa performed a total of 85,869 aesthetic procedures in 2023, with 48,486 being non-surgical, predominantly involving injectable treatments like botulinum toxin and hyaluronic acid.

The aging population, increasing disposable incomes, and evolving lifestyle trends in both southern and northern Africa are expected to further bolster the growth of the aesthetic injectable devices market. The demand for non-invasive procedures that mitigate signs of aging is on the rise, particularly as the population ages. As reported by the National Osteoporosis Foundation of South Africa, approximately 16% of the South African population was over 50 years old in 2022, a figure projected to increase significantly over the next two decades. This demographic shift is expected to drive demand for anti-aging treatments, highlighting a strong consumer interest in wrinkle reduction and facial rejuvenation therapies.

Company Profiles

Key players in the MEA Aesthetic Injectable Devices Market include Merz Pharma GmbH & Co KGaA, AbbVie Inc, Ipsen SA, Mesoestetic E-Commerce SL, Galderma SA, Revance Therapeutics Inc, Medytox Inc, Sinopharm Group Co Ltd, Evolus Inc, Hugel Inc, Sinclair Pharma Ltd, and Laboratoires Vivacy, S.A.S. These companies are employing various strategies, including expansion, product innovation, and mergers and acquisitions, to enhance their product offerings and increase market share.

Product Code: TIPRE00041912

1. Introduction

1.1 Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macroeconomic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country-level data:

4. Aesthetic Injectable Devices Market Landscape

4.2 PEST Analysis
4.3 Global and Regional Average Cost Range, 2024

4. Middle East & Africa Aesthetic Injectable Devices Market - Key Market Dynamics

4.1 Market Drivers
4.2 Market Restraints
4.3 Market Opportunities
4.4 Future Trends
4.5 Impact of Drivers and Restraints:

5. Aesthetic Injectable Devices Market - Middle East & Africa Market Analysis

5.1 Middle East & Africa Aesthetic Injectable Devices Market Revenue (US$ Million), 2024 - 2031
5.2 Middle East & Africa Aesthetic Injectable Devices Market Forecast and Analysis

6. Middle East & Africa Aesthetic Injectable Devices Market Revenue Analysis - by Product

6.1 Dermal Filler
- 6.1.1 Overview
- 6.1.2 Dermal Filler: Middle East & Africa Aesthetic Injectable Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
6.2 Botulinum Toxin
- 6.2.1 Overview
- 6.2.2 Botulinum Toxin: Middle East & Africa Aesthetic Injectable Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
6.3 Others
- 6.3.1 Overview
- 6.3.2 Others: Middle East & Africa Aesthetic Injectable Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)

7. Middle East & Africa Aesthetic Injectable Devices Market Revenue Analysis - by Dermal Fillers

7.1 Calcium Hydroxylapatite
- 7.1.1 Overview
- 7.1.2 Calcium Hydroxylapatite: Middle East & Africa Aesthetic Injectable Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.2 Hyaluronic Acid
- 7.2.1 Overview
- 7.2.2 Hyaluronic Acid: Middle East & Africa Aesthetic Injectable Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.3 Collagen
- 7.3.1 Overview
- 7.3.2 Collagen: Middle East & Africa Aesthetic Injectable Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.4 Poly-L-Lactic Acid
- 7.4.1 Overview
- 7.4.2 Poly-L-Lactic Acid: Middle East & Africa Aesthetic Injectable Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.5 Polymethylmethacrylate (PMMA)
- 7.5.1 Overview
- 7.5.2 Polymethylmethacrylate (PMMA): Middle East & Africa Aesthetic Injectable Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.6 Fat Fillers
- 7.6.1 Overview
- 7.6.2 Fat Fillers: Middle East & Africa Aesthetic Injectable Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.7 Others
- 7.7.1 Overview
- 7.7.2 Others: Middle East & Africa Aesthetic Injectable Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)

8. Middle East & Africa Aesthetic Injectable Devices Market Revenue Analysis - by Device

8.1 Microcannulas
- 8.1.1 Overview
- 8.1.2 Microcannulas: Middle East & Africa Aesthetic Injectable Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.2 Pre-Filled Syringes
- 8.2.1 Overview
- 8.2.2 Pre-Filled Syringes: Middle East & Africa Aesthetic Injectable Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.3 Mesotherapy Guns
- 8.3.1 Overview
- 8.3.2 Mesotherapy Guns: Middle East & Africa Aesthetic Injectable Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.4 Others
- 8.4.1 Overview
- 8.4.2 Others: Middle East & Africa Aesthetic Injectable Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)

9. Middle East & Africa Aesthetic Injectable Devices Market Revenue Analysis - by Application

9.1 Facial Line Correction
- 9.1.1 Overview
- 9.1.2 Facial Line Correction: Middle East & Africa Aesthetic Injectable Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.2 Face Lift
- 9.2.1 Overview
- 9.2.2 Face Lift: Middle East & Africa Aesthetic Injectable Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.3 Lip Treatment
- 9.3.1 Overview
- 9.3.2 Lip Treatment: Middle East & Africa Aesthetic Injectable Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.4 Anti-Ageing and Wrinkle Treatment
- 9.4.1 Overview
- 9.4.2 Anti-Ageing and Wrinkle Treatment: Middle East & Africa Aesthetic Injectable Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.5 Acne and Scar Treatment
- 9.5.1 Overview
- 9.5.2 Acne and Scar Treatment: Middle East & Africa Aesthetic Injectable Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.6 Stretch Marks
- 9.6.1 Overview
- 9.6.2 Stretch Marks: Middle East & Africa Aesthetic Injectable Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.7 Others
- 9.7.1 Overview
- 9.7.2 Others: Middle East & Africa Aesthetic Injectable Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)

10. Middle East & Africa Aesthetic Injectable Devices Market Revenue Analysis - by Age Group

10.1 Up to 30
- 10.1.1 Overview
- 10.1.2 Up to 30: Middle East & Africa Aesthetic Injectable Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.2 31-40
- 10.2.1 Overview
- 10.2.2 31-40: Middle East & Africa Aesthetic Injectable Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.3 41-50
- 10.3.1 Overview
- 10.3.2 41-50: Middle East & Africa Aesthetic Injectable Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.4 51-60
- 10.4.1 Overview
- 10.4.2 51-60: Middle East & Africa Aesthetic Injectable Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.5 More Than 60
- 10.5.1 Overview
- 10.5.2 More Than 60: Middle East & Africa Aesthetic Injectable Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)

11. Middle East & Africa Aesthetic Injectable Devices Market Revenue Analysis - by Gender

11.1 Female
- 11.1.1 Overview
- 11.1.2 Female: Middle East & Africa Aesthetic Injectable Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
11.2 Male
- 11.2.1 Overview
- 11.2.2 Male: Middle East & Africa Aesthetic Injectable Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)

12. Middle East & Africa Aesthetic Injectable Devices Market Revenue Analysis - by End User

12.1 Medical Spas
- 12.1.1 Overview
- 12.1.2 Medical Spas: Middle East & Africa Aesthetic Injectable Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
12.2 Dermatology Clinics
- 12.2.1 Overview
- 12.2.2 Dermatology Clinics: Middle East & Africa Aesthetic Injectable Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
12.3 Hospitals
- 12.3.1 Overview
- 12.3.2 Hospitals: Middle East & Africa Aesthetic Injectable Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
12.4 Others
- 12.4.1 Overview
- 12.4.2 Others: Middle East & Africa Aesthetic Injectable Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)

13. Middle East & Africa Aesthetic Injectable Devices Market - Country Analysis

13.1 Middle East & Africa
- 13.1.1 Middle East & Africa Aesthetic Injectable Devices Market Revenue and Forecast and Analysis - by Country
  - 13.1.1.1 Middle East & Africa Aesthetic Injectable Devices Market Revenue and Forecast and Analysis - by Country
  - 13.1.2.2 Saudi Arabia: Middle East & Africa Aesthetic Injectable Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
    - 13.1.2.2.1 Saudi Arabia: Middle East & Africa Aesthetic Injectable Devices Market Share - by Product
    - 13.1.2.2.2 Saudi Arabia: Middle East & Africa Aesthetic Injectable Devices Market Share - by Dermal Fillers
    - 13.1.2.2.3 Saudi Arabia: Middle East & Africa Aesthetic Injectable Devices Market Share - by Device
    - 13.1.2.2.4 Saudi Arabia: Middle East & Africa Aesthetic Injectable Devices Market Share - by Application
    - 13.1.2.2.5 Saudi Arabia: Middle East & Africa Aesthetic Injectable Devices Market Share - by Age Group
    - 13.1.2.2.6 Saudi Arabia: Middle East & Africa Aesthetic Injectable Devices Market Share - by Gender
    - 13.1.2.2.7 Saudi Arabia: Middle East & Africa Aesthetic Injectable Devices Market Share - by End User
  - 13.2.3.3 South Africa: Middle East & Africa Aesthetic Injectable Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
    - 13.2.3.3.1 South Africa: Middle East & Africa Aesthetic Injectable Devices Market Share - by Product
    - 13.2.3.3.2 South Africa: Middle East & Africa Aesthetic Injectable Devices Market Share - by Dermal Fillers
    - 13.2.3.3.3 South Africa: Middle East & Africa Aesthetic Injectable Devices Market Share - by Device
    - 13.2.3.3.4 South Africa: Middle East & Africa Aesthetic Injectable Devices Market Share - by Application
    - 13.2.3.3.5 South Africa: Middle East & Africa Aesthetic Injectable Devices Market Share - by Age Group
    - 13.2.3.3.6 South Africa: Middle East & Africa Aesthetic Injectable Devices Market Share - by Gender
    - 13.2.3.3.7 South Africa: Middle East & Africa Aesthetic Injectable Devices Market Share - by End User
  - 13.3.4.4 United Arab Emirates: Middle East & Africa Aesthetic Injectable Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
    - 13.3.4.4.1 United Arab Emirates: Middle East & Africa Aesthetic Injectable Devices Market Share - by Product
    - 13.3.4.4.2 United Arab Emirates: Middle East & Africa Aesthetic Injectable Devices Market Share - by Dermal Fillers
    - 13.3.4.4.3 United Arab Emirates: Middle East & Africa Aesthetic Injectable Devices Market Share - by Device
    - 13.3.4.4.4 United Arab Emirates: Middle East & Africa Aesthetic Injectable Devices Market Share - by Application
    - 13.3.4.4.5 United Arab Emirates: Middle East & Africa Aesthetic Injectable Devices Market Share - by Age Group
    - 13.3.4.4.6 United Arab Emirates: Middle East & Africa Aesthetic Injectable Devices Market Share - by Gender
    - 13.3.4.4.7 United Arab Emirates: Middle East & Africa Aesthetic Injectable Devices Market Share - by End User
  - 13.4.5.5 Rest of Middle East & Africa: Middle East & Africa Aesthetic Injectable Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
    - 13.4.5.5.1 Rest of Middle East & Africa: Middle East & Africa Aesthetic Injectable Devices Market Share - by Product
    - 13.4.5.5.2 Rest of Middle East & Africa: Middle East & Africa Aesthetic Injectable Devices Market Share - by Dermal Fillers
    - 13.4.5.5.3 Rest of Middle East & Africa: Middle East & Africa Aesthetic Injectable Devices Market Share - by Device
    - 13.4.5.5.4 Rest of Middle East & Africa: Middle East & Africa Aesthetic Injectable Devices Market Share - by Application
    - 13.4.5.5.5 Rest of Middle East & Africa: Middle East & Africa Aesthetic Injectable Devices Market Share - by Age Group
    - 13.4.5.5.6 Rest of Middle East & Africa: Middle East & Africa Aesthetic Injectable Devices Market Share - by Gender
    - 13.4.5.5.7 Rest of Middle East & Africa: Middle East & Africa Aesthetic Injectable Devices Market Share - by End User

14 Competitive Landscape

14.1 Heat Map Analysis by Key Players
14.2 Company Positioning & Concentration

15 Industry Landscape

15.1 Overview
15.2 New Product Development
15.3 Merger and Acquisition
15.4 Other Strategic Developments

17 COMPANY PROFILES

16.1 Merz Pharma GmbH & Co KGaA
- 16.1.1 Key Facts
- 16.1.2 Business Description
- 16.1.3 Products and Services
- 16.1.4 Financial Overview
- 16.1.5 SWOT Analysis
- 16.1.6 Key Developments
16.2 AbbVie Inc
- 16.2.1 Key Facts
- 16.2.2 Business Description
- 16.2.3 Products and Services
- 16.2.4 Financial Overview
- 16.2.5 SWOT Analysis
- 16.2.6 Key Developments
16.3 Ipsen SA
- 16.3.1 Key Facts
- 16.3.2 Business Description
- 16.3.3 Products and Services
- 16.3.4 Financial Overview
- 16.3.5 SWOT Analysis
- 16.3.6 Key Developments
16.4 Mesoestetic E-Commerce SL
- 16.4.1 Key Facts
- 16.4.2 Business Description
- 16.4.3 Products and Services
- 16.4.4 Financial Overview
- 16.4.5 SWOT Analysis
- 16.4.6 Key Developments
16.5 Galderma SA
- 16.5.1 Key Facts
- 16.5.2 Business Description
- 16.5.3 Products and Services
- 16.5.4 Financial Overview
- 16.5.5 SWOT Analysis
- 16.5.6 Key Developments
16.6 Revance Therapeutics Inc
- 16.6.1 Key Facts
- 16.6.2 Business Description
- 16.6.3 Products and Services
- 16.6.4 Financial Overview
- 16.6.5 SWOT Analysis
- 16.6.6 Key Developments
16.7 Medytox Inc
- 16.7.1 Key Facts
- 16.7.2 Business Description
- 16.7.3 Products and Services
- 16.7.4 Financial Overview
- 16.7.5 SWOT Analysis
- 16.7.6 Key Developments
16.8 Sinopharm Group Co Ltd
- 16.8.1 Key Facts
- 16.8.2 Business Description
- 16.8.3 Products and Services
- 16.8.4 Financial Overview
- 16.8.5 SWOT Analysis
- 16.8.6 Key Developments
16.9 Evolus Inc
- 16.9.1 Key Facts
- 16.9.2 Business Description
- 16.9.3 Products and Services
- 16.9.4 Financial Overview
- 16.9.5 SWOT Analysis
- 16.9.6 Key Developments
16.10 Hugel Inc
- 16.10.1 Key Facts
- 16.10.2 Business Description
- 16.10.3 Products and Services
- 16.10.4 Financial Overview
- 16.10.5 SWOT Analysis
- 16.10.6 Key Developments
16.11 Sinclair Pharma Ltd
- 16.11.1 Key Facts
- 16.11.2 Business Description
- 16.11.3 Products and Services
- 16.11.4 Financial Overview
- 16.11.5 SWOT Analysis
- 16.11.6 Key Developments
16.12 Laboratoires Vivacy, S.A.S.
- 16.12.1 Key Facts
- 16.12.2 Business Description
- 16.12.3 Products and Services
- 16.12.4 Financial Overview
- 16.12.5 SWOT Analysis
- 16.12.6 Key Developments

17. Appendix

17.1 About The Insight Partners